Detalles de la búsqueda
1.
Adjuvant nivolumab plus ipilimumab versus placebo for localised renal cell carcinoma after nephrectomy (CheckMate 914): a double-blind, randomised, phase 3 trial.
Lancet
; 401(10379): 821-832, 2023 03 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36774933
2.
Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol.
Lancet Oncol
; 24(5): 443-456, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37142371
3.
Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol.
Lancet
; 399(10323): 447-460, 2022 01 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-34953525
4.
Addition of nintedanib or placebo to neoadjuvant gemcitabine and cisplatin in locally advanced muscle-invasive bladder cancer (NEOBLADE): a double-blind, randomised, phase 2 trial.
Lancet Oncol
; 23(5): 650-658, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35421369
5.
Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476).
Int J Cancer
; 151(3): 422-434, 2022 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35411939
6.
Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial.
PLoS Med
; 19(6): e1003998, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35671327
7.
Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial.
Lancet Oncol
; 21(1): 162-174, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31806540
8.
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.
N Engl J Med
; 377(4): 338-351, 2017 07 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-28578639
9.
Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial.
Lancet
; 392(10162): 2353-2366, 2018 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30355464
10.
Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial.
Lancet
; 387(10024): 1163-77, 2016 Mar 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-26719232
11.
Targeted Inhibition of CYP11A1 in Castration-Resistant Prostate Cancer.
NEJM Evid
; 3(1): EVIDoa2300171, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38320513
12.
Clinical Outcomes of Tivozanib Monotherapy as First-Line Treatment for Metastatic Renal Cell Carcinoma: A Multicentric UK Real-World Analysis.
Target Oncol
; 18(4): 593-599, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37285073
13.
A Randomized, Double-Blind, Biomarker-Selected, Phase II Clinical Trial of Maintenance Poly ADP-Ribose Polymerase Inhibition With Rucaparib Following Chemotherapy for Metastatic Urothelial Carcinoma.
J Clin Oncol
; 41(1): 54-64, 2023 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35960902
14.
Summary of Research: Adjuvant Nivolumab Plus Ipilimumab Versus Placebo for Localized Renal Cell Carcinoma After Nephrectomy (CheckMate 914): A Double-Blind, Randomized, Phase 3 Trial.
Target Oncol
; 18(5): 639-641, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37659025
15.
Real-world Treatment Sequencing in Patients with Metastatic Castration-resistant Prostate Cancer: Results from the Prospective, International, Observational Prostate Cancer Registry.
Eur Urol Open Sci
; 45: 12-22, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36353661
16.
Ilixadencel, a Cell-based Immune Primer, plus Sunitinib Versus Sunitinib Alone in Metastatic Renal Cell Carcinoma: A Randomized Phase 2 Study.
Eur Urol Open Sci
; 40: 38-45, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35638086
17.
Decrease of Pro-Angiogenic Monocytes Predicts Clinical Response to Anti-Angiogenic Treatment in Patients with Metastatic Renal Cell Carcinoma.
Cells
; 11(1)2021 12 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-35011579
18.
Genomics of lethal prostate cancer at diagnosis and castration resistance.
J Clin Invest
; 130(4): 1743-1751, 2020 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31874108
19.
Severe thrombocytopenia induced by a single infusion of trastuzumab.
Clin Breast Cancer
; 8(3): 285-6, 2008 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-18650161
20.
Addition of Docetaxel to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Modelling to Estimate Long-term Survival, Quality-adjusted Survival, and Cost-effectiveness.
Eur Urol Oncol
; 1(6): 449-458, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31158087